January 20-22 (Thursday - Saturday), 2000, National Science Seminar complex, Indian Institute of Science, Bangalore, Karnataka, India
Goals and Objectives | Programme and slides of the meeting | Host Institutions | Credits
The
slides presented by the some of the speakers at this workshop are available
on this site as "Web slide shows" (view per slide) and as "PDF files" (download
the whole presentation). To access either of tehm, click on the title
of the lectures. These slides, which reflect the views of their authors
and should not be taken as being endorsed by ISAP, are for information
purposes only. They cannot be reproduced or used for any form of
presentations without the autorization of their author and of ISAP. Please,
contact the ISAP Webmaster for
further information.
|
|
|
One of the main goals of ISAP is to disseminate the concepts as well as the practical knowledge of Pharmacokinetics and Pharmacodynamics (PK/PD) of antiinfectives within the scientific and clinical community. In this context, ISAP is regularly sponsoring scientific meetings where ISAP members and/or experts in PK/PD of antiinfectives address invited audiences to review the recent progresses, discuss their potential applications and answer specific questions in their domains of expertise.
The present
meeting was typically meant at bringing to an international audience, with
emphasis on Asia, the knowledge developed by ISAP over the last years through
the scientific activities of its members on the one hand and through contacts
with regulatory agencies on the other hand, so that new drugs will be used
in the most appropriate fashion with respect to the three main criteria
of efficacy, lack of toxicity and prevention of emergence of resistance.
The symposium dealt with pharmacodynamic and parmacokinetic properties
of antibacterial agents as determined in in vitro and in vivo
models and their use for prediction and evaluation of the performance of
the agents and the use of this information for development, clinical use
and registration of
the latter. Special attention
was also be given to tuberculosis, an old but still highly threatening
disease in emerging countries.
The meeting was open all scientists in academia and industry. The focus
of the programme was on active interaction with the audience in order to
provide both researchers and clinicians an as effective as possible guidance
for successful future work and achievements in antiinfective therapy.
Host
Institutions
Astra Research Centre India (ARCI).
ARCI is situated in Bangalore, state of Karnataka, India and was founded in 1986. It is a non-profit organization, a Society under the laws of Karnataka, with the objective to support scientific developments in India, particularly with regard to infectious diseases. The Society, comprising Indian and Swedish scientists as members, is headed by a Director, Dr. S. Anand Kumar and has a Governing Board with three members appointed by the Government of India, Department of Science and Technology and three members appointed by Astra AB, Sweden (now AstraZeneca, PLC, UK). The activities of ARCI are financed mainly by returns on a corpus fund owned by the Society and to some extent by a contribution from AstraZeneca. The Society has decided to change its name into AstraZeneca Research Foundation India but the new name has not yet become official.
Indian Institute of Science (IISc)
Started in 1909 through the pioneering vision of J.N. Tata, IIScin Bangalore has grown into a premier institution of research and advanced instruction (2000 researchers) in frontier areas of science and technology, with a very high international standing.
The National Center for Biological Sciences (NCBS)
New centre of the Tata Institute
of Fundamental Research, NCBS conducts basic research in the frontier areas
of Structural and Cell Biology, Biology of Disease,
Neurogenetics, and Molecular and Systems Neuroscience.
Back
to ISAP home page